Fusion Pharmaceuticals Inc

General ticker "FUSN" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $808.8M

Fusion Pharmaceuticals Inc follows the US Stock Market performance with the rate: 46.5%.

Estimated limits based on current volatility of 0.2%: low 21.46$, high 21.54$

Factors to consider:

  • Current price 85.8% above predicted high
  • Earnings for 3 months up through Q1 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term predictions were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 predicted range: [4.58$, 11.60$]
  • 2024-12-30 to 2025-12-30 predicted range: [5.47$, 13.05$]

Financial Metrics affecting the FUSN estimates:

  • Negative: Non-GAAP EPS of -1.47 <= 0.08
  • Negative: Operating Income to Revenue ratio of -0.98 <= 0.01
  • Negative: Operating Cash Flow per share of -1.25 <= 0.20
  • Negative: negative Net Income
  • Negative: 0 < Interest Expense per share of 0.08
  • Negative: Industry Operating Cash Flow per share (median) of -1.49 <= 0.29

Similar symbols

Short-term FUSN quotes

Long-term FUSN plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $1.44MM $1.46MM $2.07MM
Operating Expenses $83.45MM $89.50MM $101.30MM
Operating Income $-82.02MM $-88.03MM $-99.23MM
Non-Operating Income $0.85MM $-1.42MM $5.12MM
Interest Expense $0.00MM $1.80MM $5.17MM
R&D Expense $56.36MM $58.90MM $68.76MM
Income(Loss) $-81.17MM $-89.45MM $-94.11MM
Taxes $-0.12MM $-1.84MM $0.79MM
Profit(Loss) $-81.05MM $-87.61MM $-94.90MM
Stockholders Equity $231.46MM $162.22MM $222.48MM
Assets $252.27MM $219.06MM $285.84MM
Operating Cash Flow $-75.74MM $-73.28MM $-81.80MM
Investing Cash Flow $37.77MM $23.09MM $-42.76MM
Financing Cash Flow $0.35MM $40.73MM $142.01MM
Earnings Per Share* $-1.90 $-2.00 $-1.45

* EPS are Split Adjusted, recent splits may be reflected with a delay.